Steve N. Slilaty
2022
In 2022, Steve N. Slilaty earned a total compensation of $370K as Chief Executive Officer and Director at Sunshine Biopharma, a 20% decrease compared to previous year.
Compensation breakdown
| Bonus | $10,000 |
|---|---|
| Salary | $360,000 |
| Total | $370,000 |
Slilaty received $360K in salary, accounting for 97% of the total pay in 2022.
Slilaty also received $10K in bonus.
Rankings
In 2022, Steve N. Slilaty's compensation ranked 4,817th out of 5,756 executives tracked by ExecPay. In other words, Slilaty earned more than 16.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,817 out of 5,756 | 16th |
Division Manufacturing | 2,672 out of 3,133 | 15th |
Major group Chemicals And Allied Products | 1,256 out of 1,419 | 12th |
Industry group Drugs | 1,181 out of 1,320 | 11th |
Industry Pharmaceutical Preparations | 864 out of 966 | 11th |
Source: SEC filing on October 18, 2023.
Slilaty's colleagues
We found two more compensation records of executives who worked with Steve N. Slilaty at Sunshine Biopharma in 2022.